placeholder image
W. C. Cushman All authors
About
Publications While At HealthPartners
Highlights
selected publications
Journal Article
  • Average clinician-measured blood pressures and cardiovascular outcomes in patients with type 2 diabetes mellitus and ischemic heart disease in the EXAMINE Trial. 
    Journal of the American Heart Association. 2018
  • Total cardiovascular events analysis of the EXAMINE trial in patients with type 2 diabetes and recent acute coronary syndrome. 
    Clinical Cardiology. 2018
  • Association of 3 different antihypertensive medications with hip and pelvic fracture risk in older adults: secondary analysis of a randomized clinical trial. 
    JAMA internal medicine. 2017
  • Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: the EXAMINE trial. 
    Diabetes, Obesity & Metabolism. 2017
  • Angiotensin-converting enzyme inhibitor use and major cardiovascular outcomes in type 2 diabetes mellitus treated with the dipeptidyl peptidase 4 inhibitor alogliptin. 
    Hypertension (Dallas, Tex.. 2016
  • Cardiovascular mortality in patients with type 2 diabetes and recent acute coronary syndromes from the EXAMINE Trial. 
    Diabetes care. 2016
  • Orthostatic hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) blood pressure trial: prevalence, incidence, and prognostic significance. 
    Hypertension (Dallas, Tex.. 2016
  • Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial. 
    Diabetes care. 2014
  • Alogliptin after acute coronary syndrome in patients with type 2 diabetes. 
    New England Journal of Medicine. 2013
  • Mortality and morbidity during and after Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: results by sex. 
    Hypertension (Dallas, Tex.. 2013
  • Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients. 
    Kidney International. 2012
  • Long-term effects of incident diabetes mellitus on cardiovascular outcomes in people treated for hypertension: the ALLHAT Diabetes Extension Study. 
    Circulation: Cardiovascular Quality and Outcomes. 2012
  • EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome (EXAMINE): a cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndrome. 
    American Heart Journal. 2011
  • Long-term effects of intensive glucose lowering on cardiovascular outcomes. 
    New England Journal of Medicine. 2011
  • Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. 
    Lancet (London, England). 2010
  • Effects of combination lipid therapy in type 2 diabetes mellitus. 
    New England Journal of Medicine. 2010
  • Effects of intensive blood-pressure control in type 2 diabetes mellitus. 
    New England Journal of Medicine. 2010
  • Effects of medical therapies on retinopathy progression in type 2 diabetes. 
    New England Journal of Medicine. 2010
  • ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses. 
    Archives of Internal Medicine. 2009
  • Effects of intensive glucose lowering in type 2 diabetes. 
    New England Journal of Medicine. 2008
  • Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. 
    American Journal of Cardiology. 2007
  • Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. 
    Hypertension (Dallas, Tex.. 2007
    • Review
  • Blood pressure assessment in adults in clinical practice and clinic-based research: JACC Scientific Expert Panel [review]. 
    Journal of the American College of Cardiology. 2019
  • Research needs to improve hypertension treatment and control in African Americans [review]. 
    Hypertension (Dallas, Tex.. 2016
  • Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial [review]. 
    American Journal of Cardiology. 2007
    • Abstract
  • Mortality findings from the EXAMINE Trial [abstract]. 
    Diabetes. 2016
  • Major cardiovascular outcomes in the EXAMINE trial according to ACE inhibitor use [abstract]. 
    Diabetes. 2015
  • Microvascular effects of intensive blood pressure control and its relation to glycaemic control in the ACCORD blood pressure trial [abstract]. 
    Diabetologia. 2011
    • presentations
    Contact
    full name
  • W. C. Cushman
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
    Collaboration